Loss of myeloid HIF-2α has been linked to decreased tumor inflammation and progression in murine models of breast and gastric cancer (13, 14), while tumor-associated myeloid cells can also contribute to immune suppression by production of nitric oxide (NO), acting through the HIF-1α-NOS2 pathway (4, 7). The gene discussed is NOS2; the disease is neoplasm.